224 related articles for article (PubMed ID: 21734355)
1. Neuropeptides as pleiotropic modulators of the immune response.
Souza-Moreira L; Campos-Salinas J; Caro M; Gonzalez-Rey E
Neuroendocrinology; 2011; 94(2):89-100. PubMed ID: 21734355
[TBL] [Abstract][Full Text] [Related]
2. Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
Gonzalez-Rey E; Delgado M
Mol Cell Endocrinol; 2008 May; 286(1-2):135-40. PubMed ID: 17850953
[TBL] [Abstract][Full Text] [Related]
3. Keeping the balance between immune tolerance and pathogen immunity with endogenous neuropeptides.
Gonzalez-Rey E
Neuroimmunomodulation; 2010; 17(3):161-4. PubMed ID: 20134192
[TBL] [Abstract][Full Text] [Related]
4. Regulation of immune tolerance by anti-inflammatory neuropeptides.
Gonzalez-Rey E; Chorny A; Delgado M
Nat Rev Immunol; 2007 Jan; 7(1):52-63. PubMed ID: 17186031
[TBL] [Abstract][Full Text] [Related]
5. Role of Cortistatin in the Stressed Immune System.
Delgado M; Gonzalez-Rey E
Front Horm Res; 2017; 48():110-120. PubMed ID: 28245456
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents.
Delgado M; Ganea D
Brain Behav Immun; 2008 Nov; 22(8):1146-51. PubMed ID: 18598752
[TBL] [Abstract][Full Text] [Related]
7. Immune-neuroendocrine interactions and autoimmune diseases.
Jara LJ; Navarro C; Medina G; Vera-Lastra O; Blanco F
Clin Dev Immunol; 2006; 13(2-4):109-23. PubMed ID: 17162354
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptides as therapeutic approach to autoimmune diseases.
Gonzalez-Rey E; Delgado-Maroto V; Souza Moreira L; Delgado M
Curr Pharm Des; 2010; 16(28):3158-72. PubMed ID: 20687881
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
Gonzalez-Rey E; Delgado M
Trends Pharmacol Sci; 2007 Sep; 28(9):482-91. PubMed ID: 17688953
[TBL] [Abstract][Full Text] [Related]
10. Immune modulation in gastrointestinal disorders: new opportunities for therapeutic peptides?
de Jonge WJ; Greaves DR
Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):741-8. PubMed ID: 19090735
[TBL] [Abstract][Full Text] [Related]
11. Cortistatin as a potential multistep therapeutic agent for inflammatory disorders.
Gonzalez-Rey E; Delgado M
Drug News Perspect; 2006 Sep; 19(7):393-9. PubMed ID: 17080202
[TBL] [Abstract][Full Text] [Related]
12. Is chronic fatigue syndrome an autoimmune disorder of endogenous neuropeptides, exogenous infection and molecular mimicry?
Staines DR
Med Hypotheses; 2004; 62(5):646-52. PubMed ID: 15082083
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide regulates Th17 function in autoimmune inflammation.
Leceta J; Gomariz RP; Martinez C; Carrión M; Arranz A; Juarranz Y
Neuroimmunomodulation; 2007; 14(3-4):134-8. PubMed ID: 18073504
[TBL] [Abstract][Full Text] [Related]
14. The galanin peptide family in inflammation.
Lang R; Kofler B
Neuropeptides; 2011 Feb; 45(1):1-8. PubMed ID: 21087790
[TBL] [Abstract][Full Text] [Related]
15. Endogenous anti-inflammatory neuropeptides and pro-resolving lipid mediators: a new therapeutic approach for immune disorders.
Anderson P; Delgado M
J Cell Mol Med; 2008 Oct; 12(5B):1830-47. PubMed ID: 18554314
[TBL] [Abstract][Full Text] [Related]
16. Tuning inflammation with anti-inflammatory neuropeptides.
Varela N; Chorny A; Gonzalez-Rey E; Delgado M
Expert Opin Biol Ther; 2007 Apr; 7(4):461-78. PubMed ID: 17373898
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide receptors in intestinal disease: physiology and therapeutic potential.
Snoek SA; Borensztajn KS; van den Wijngaard RM; de Jonge WJ
Curr Pharm Des; 2010; 16(9):1091-105. PubMed ID: 20030609
[TBL] [Abstract][Full Text] [Related]
18. Is fibromyalgia an autoimmune disorder of endogenous vasoactive neuropeptides?
Staines DR
Med Hypotheses; 2004; 62(5):665-9. PubMed ID: 15082086
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.
Ferone D; Boschetti M; Resmini E; Giusti M; Albanese V; Goglia U; Albertelli M; Vera L; Bianchi F; Minuto F
Ann N Y Acad Sci; 2006 Jun; 1069():129-44. PubMed ID: 16855140
[TBL] [Abstract][Full Text] [Related]
20. Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
Pozo D; Gonzalez-Rey E; Chorny A; Anderson P; Varela N; Delgado M
Peptides; 2007 Sep; 28(9):1833-46. PubMed ID: 17521775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
